NRC Health— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$35M
↓-4.6% -$2Mvs FY2024 (Q4)
Gross Profit
$35M
↓-4.6% -$2Mvs FY2024 (Q4)
Operating Income
$5M
↓-51.3% -$5Mvs FY2024 (Q4)
Net Income
$2M
↓-72.6% -$5Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $35M | $37M |
| COGS | $0 | $0 |
| Gross Profit | $35M | $37M |
| R&D | $0 | $0 |
| SG&A | $14M | $11M |
| D&A | $2M | $2M |
| Other OpEx | $14M | $14M |
| Operating Income | $5M | $10M |
| Interest Exp. | $1M | $713K |
| Other Non-Op | $0 | $0 |
| Pretax Income | $3M | $9M |
| Tax | $1M | $2M |
| Net Income | $2M | $7M |
QuarterCharts · SEC EDGAR data · NRC · Comparing FY2025 (Q4) vs FY2024 (Q4)